Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hodge

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|October 13, 2016
Connecting (T)issues: How Research in Fascia Biology Can Impact Integrative OncologyHelene M Langevin, Patricia Keely, Jun Mao, et al.
European Journal of Pharmacology|February 4, 2014
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark miceKaren M Smith, Susan E Browne, Srinivasan Jayaraman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2012
A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's diseaseEmmanuel Le Poul, Christelle Boléa, Francoise Girard, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|October 13, 2016
Connecting (T)issues: How Research in Fascia Biology Can Impact Integrative OncologyHelene M Langevin, Patricia Keely, Jun Mao, et al.
European Journal of Pharmacology|February 4, 2014
Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark miceKaren M Smith, Susan E Browne, Srinivasan Jayaraman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2012
A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's diseaseEmmanuel Le Poul, Christelle Boléa, Francoise Girard, et al.
Pageof 3